PMID- 34558866 OWN - NLM STAT- MEDLINE DCOM- 20210927 LR - 20220531 IS - 1976-2437 (Electronic) IS - 0513-5796 (Print) IS - 0513-5796 (Linking) VI - 62 IP - 10 DP - 2021 Oct TI - Clinical Implication of Hypoxic Liver Injury for Predicting Hypoxic Hepatitis and In-Hospital Mortality in ST Elevation Myocardial Infarction Patients. PG - 877-884 LID - 10.3349/ymj.2021.62.10.877 [doi] AB - PURPOSE: In this study, we aimed to determine the value of hypoxic liver injury (HLI) in the emergency room (ER) for predicting hypoxic hepatitis (HH) and in-hospital mortality in ST elevation myocardial infarction (STEMI) patients. MATERIALS AND METHODS: 1537 consecutive STEMI patients were enrolled. HLI in the ER was defined as a >/=2-fold increase in serum aspartate transaminase (AST). HH was defined as a >/=20-fold increase in peak serum transaminase. Patients were divided into four groups according to HLI and HH status (group 1, no HLI or HH; group 2, HLI, but no HH; group 3, no HLI, but HH; group 4, both HLI and HH). RESULTS: The incidences of HLI and HH in the ER were 22% and 2%, respectively. In-hospital mortality rates were 3.1%, 11.8%, 28.6%, and 47.1% for groups 1, 2, 3, and 4, respectively. Patients with HLI and/or HH had worse Killip class, higher cardiac biomarker elevations, and lower left ventricular ejection fraction. Multivariate logistic regression analysis showed that HLI in the ER was an independent predictor of HH [odds ratio 2.572, 95% confidence interval (CI) 1.166-5.675, p=0.019]. The predictive value of HLI in the ER for the development of HH during hospitalization was favorable [area under the curve (AUC) 0.737, 95% CI 0.643-0.830, sensitivity 0.548, specificity 0.805, for cut-off value AST >80]. Furthermore, in terms of in-hospital mortality, predictive values of HLI in the ER and HH during hospitalization were comparable (AUC 0.701 for HLI at ER and AUC 0.674 for HH). CONCLUSION: Among STEMI patients, HLI in the ER is a significant predictor for the development of HH and mortality during hospitalization (INTERSTELLAR ClinicalTrials.gov number, NCT02800421). CI - (c) Copyright: Yonsei University College of Medicine 2021. FAU - Choi, Seong Huan AU - Choi SH AUID- ORCID: 0000-0001-8253-9242 AD - Department of Cardiology, Inha University Hospital, Incheon, Korea. FAU - Jang, Ho-Jun AU - Jang HJ AUID- ORCID: 0000-0001-9891-2603 AD - Department of Cardiology, Sejong General Hospital, Bucheon, Korea. FAU - Suh, Young Ju AU - Suh YJ AUID- ORCID: 0000-0002-6816-8067 AD - Department of Biomedical Sciences, College of Medicine, Inha University, Incheon, Korea. FAU - Park, Sang-Don AU - Park SD AUID- ORCID: 0000-0003-0128-9988 AD - Department of Cardiology, Inha University Hospital, Incheon, Korea. FAU - Oh, Pyung Chun AU - Oh PC AUID- ORCID: 0000-0002-9955-223X AD - Department of Cardiology, Gil Medical Center, Gachon University, Incheon, Korea. FAU - Moon, Jeonggeun AU - Moon J AUID- ORCID: 0000-0001-6431-2802 AD - Department of Cardiology, Gil Medical Center, Gachon University, Incheon, Korea. FAU - Lee, Kyounghoon AU - Lee K AUID- ORCID: 0000-0001-8313-9806 AD - Department of Cardiology, Gil Medical Center, Gachon University, Incheon, Korea. FAU - Suh, Jon AU - Suh J AUID- ORCID: 0000-0001-9593-8453 AD - Department of Cardiology, Soon Chun Hyang University Bucheon Hospital, Bucheon, Korea. FAU - Kang, WoongChol AU - Kang W AUID- ORCID: 0000-0003-4590-7178 AD - Department of Cardiology, Gil Medical Center, Gachon University, Incheon, Korea. FAU - Kim, Tae-Hoon AU - Kim TH AUID- ORCID: 0000-0002-4032-1285 AD - Division of Cardiology, CHA Medical Center, Ilsan Hospital, Goyang, Korea. sch.kimtaehoon@gmail.com. FAU - Kwon, Sung Woo AU - Kwon SW AUID- ORCID: 0000-0002-0679-1523 AD - Department of Cardiology, Inha University Hospital, Incheon, Korea. kwonswdr@gmail.com. LA - eng SI - ClinicalTrials.gov/NCT02800421 GR - Inha University Hospital/Korea PT - Journal Article PT - Observational Study PL - Korea (South) TA - Yonsei Med J JT - Yonsei medical journal JID - 0414003 SB - IM MH - *Hepatitis MH - Hospital Mortality MH - Humans MH - *Percutaneous Coronary Intervention MH - Prognosis MH - *ST Elevation Myocardial Infarction MH - Stroke Volume MH - Ventricular Function, Left PMC - PMC8470566 OTO - NOTNLM OT - STEMI OT - hypoxic hepatitis OT - hypoxic liver injury OT - in-hospital mortality COIS- The authors have no potential conflicts of interest to disclose. EDAT- 2021/09/25 06:00 MHDA- 2021/09/28 06:00 PMCR- 2021/10/01 CRDT- 2021/09/24 09:01 PHST- 2020/11/19 00:00 [received] PHST- 2021/06/11 00:00 [revised] PHST- 2021/07/13 00:00 [accepted] PHST- 2021/09/24 09:01 [entrez] PHST- 2021/09/25 06:00 [pubmed] PHST- 2021/09/28 06:00 [medline] PHST- 2021/10/01 00:00 [pmc-release] AID - 62.877 [pii] AID - 10.3349/ymj.2021.62.10.877 [doi] PST - ppublish SO - Yonsei Med J. 2021 Oct;62(10):877-884. doi: 10.3349/ymj.2021.62.10.877.